You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RYTM Sale Disclosure
Garfield Alastair · SEC Form 4 · Filed Aug 17, 2026
Sale
Calculated transaction value
$233.03K
Garfield Alastair Chief Scientific Officer
RYTM
Transaction date
Aug 13, 2026
Public filing date
Aug 17, 2026
Filing lag
Filed 4 days later
RYTM daily price context
Close on/before transaction
$116.02
Aug 13, 2026
First close after public filing
$115.25
Aug 18, 2026
30-day return after filing
-14.96%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,007 shares @ $116.11
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001649904-26-000013
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$912.7K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. RYTM Current | Sale | Aug 13, 2026 | $233.03K |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Aug 13, 2026 | $182.17K |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Aug 13, 2026 | $402.17K |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Aug 13, 2026 | $95.34K |